You can shop from our store and save on shipping!
We don't just make products. We publish the research that explains why vaporization is more efficient, why the science clears standard vaping ingredients, and who profits when consumers are pushed back toward combustion. Three whitepapers. 40+ citations. Free to download.
Aroma restoration, batch consistency, and post-harvest enhancement. Addresses the benzene misconception, the EVALI history, and how to evaluate a terpene spray supplier. The definitive document for commercial cannabis operators.
Dismantles the Troutt & DiDonato (2017) Arizona study on methodology and author credentials. Documents the dry puff temperature flaw, Farsalinos replication findings, CDC clearance of PG and PEG in EVALI, and the real cause of the 2019 outbreak.
The combustion efficiency science. The financial conflicts — tobacco bond obligations, Big Pharma NRT protection, PMTA regulatory capture. The PACT Act buried in COVID relief on page 5,136. The real casualties of a legislative campaign that never had consumers' interests at heart.
A practical industry guide to aroma restoration, batch consistency, and post-harvest enhancement. This paper examines the scientific mechanisms of terpene loss, evaluates three application methods — precision air-pressurized spray, infusion bags, and aerosol cans — and addresses the safety questions the cannabis community deserves straight answers to.
It also documents the role specific manufacturers played in the 2019 EVALI outbreak — including the public record of Mr. Extractor / Connoisseur Concentrates and founder Drew Jones — and establishes the verification standards consumers and commercial operators should apply when evaluating any terpene spray supplier.
Available in branded (Terps USA) and unbranded (for academic/regulatory distribution) versions. Both contain identical content and citations.
During the 2019–2020 vaping health crisis, propylene glycol (PG) and polyethylene glycol (PEG) were swept into a panic caused by an entirely different compound. A study published by a naturopathic doctor and a cannabis dispensary researcher claimed these compounds produced dangerous levels of formaldehyde when heated. That study has a fundamental, documented flaw.
Both compounds were tested at 230°C — above the threshold that produces the "dry puff" phenomenon, which causes users to immediately stop inhaling due to harsh, acrid taste. Dr. Konstantinos Farsalinos' landmark replication demonstrated that aldehyde emissions are minimal under normal vaping conditions. The Arizona study manufactured a hazard that practical use prevents.
The CDC's definitive EVALI investigation cleared PG and VG of involvement. The outbreak was caused by Vitamin E acetate. PG has a 70-year pharmaceutical inhalation history and FDA GRAS classification. PEG demonstrates consistent low-toxicity characteristics at realistic operating temperatures. This paper documents both.
The Troutt & DiDonato (2017) study tested PG and PEG at 230°C — a temperature no consumer reaches in practice because the dry puff phenomenon makes the product immediately unacceptable to inhale. Farsalinos et al. (2015) replicated and specifically corrected this: under normal vaping conditions, aldehyde emissions are minimal. The Colorado legislation that swept PG and PEG off cannabis shelves was enacted during maximum fear based on this flawed study, while the compound that actually caused EVALI — Vitamin E acetate — had already been identified and removed. Consumers and operators paid the cost of legislation that wouldn't have survived a single question about test temperature.
Available in branded and unbranded versions. The unbranded version is suitable for submission to ResearchGate, Academia.edu, and regulatory channels.
A global legislative campaign is suppressing the most efficient cannabinoid delivery technology available. It is framed as protecting public health. The financial record tells a different story.
This paper documents the combustion efficiency science — why vaporization preserves 85–90% of cannabinoids while combustion destroys 50–70% of them — and the three financial interests that benefit when consumers are pushed back toward combustion: governments protecting tobacco tax revenues and MSA bond obligations, pharmaceutical companies protecting the NRT market, and legacy tobacco corporations using regulatory compliance costs to eliminate independent competition.
It also documents the PACT Act amendment buried on page 5,136 of a COVID relief bill — and the independent cannabis businesses destroyed by a definition so broad it captured products that have nothing to do with nicotine.
On a gram of cannabis concentrate purchased for $40: combusted or dabbed hot, you receive approximately $4–$12 of effective cannabinoid delivery. Vaporized at correct temperature, you receive approximately $22–$36. The "dilution" argument against vape carts ignores the efficiency destruction happening on the other end of the nail. The consumer who has never done this math is subsidizing combustion inefficiency with every purchase.
Available in branded and unbranded versions. The unbranded version is suitable for submission to ResearchGate, Academia.edu, Scribd, and press distribution.
The same standard that produced these papers is in every product we make.